Peer Group — Developing Inclusive Youth: Promoting Intergroup Friendships and Inclusive Classrooms in Childhood
Citation(s)
Bierman, K L., & McCauley, E. (1987). Children's descriptions of their peer interactions: Useful information for clinical child assessment. Journal of Clinical Child Psychology, 16(1), 9-18. https://doi.org/10.1207/s15374424jccp1601_2
Collie, R J., Martin, A. J., Papworth, B. & Gins, P., (2016). Students' interpersonal relationships, personal best (PB) goals, and academic engagement, Learning and Individual Differences, 45, 65-76. http://dx.doi.org/10.1016/j.lindif.2015.12.002
Goodenow, C (1993). The psychological sense of school membership among adolescents: Scale development and educational correlates. Psychology in the Schools, 30, 79-90. DOI:10.1002/1520-6807.
Grutter J, Gasser L, Zuffiano A, Meyer B Promoting Inclusion Via Cross-Group Friendship: The Mediating Role of Change in Trust and Sympathy. Child Dev. 2018 Jul;89(4):e414-e430. doi: 10.1111/cdev.12883. Epub 2017 Jun 19.
Liben LS, Bigler RS The developmental course of gender differentiation: conceptualizing, measuring, and evaluating constructs and pathways. Monogr Soc Res Child Dev. 2002;67(2):i-viii, 1-147; discussion 148-83.
Mulvey KL, Rizzo MT, Killen M Challenging gender stereotypes: Theory of mind and peer group dynamics. Dev Sci. 2016 Nov;19(6):999-1010. doi: 10.1111/desc.12345. Epub 2015 Sep 22.
Van Ryzin MJ, Gravely AA, Roseth CJ Autonomy, belongingness, and engagement in school as contributors to adolescent psychological well-being. J Youth Adolesc. 2009 Jan;38(1):1-12. doi: 10.1007/s10964-007-9257-4. Epub 2007 Nov 30.
An Intervention to Promote Positive Peer Relationships and Reduce Prejudice and Bias in Childhood
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
